The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring, pharmacists say. Instead, it’s adding to
The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring, pharmacists say. Instead, it’s adding to
Biden administration limit on drug industry middlemen backfires: Pharmacists courant.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from courant.com Daily Mail and Mail on Sunday newspapers.
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.
Pharmacists: Biden admin s limit on drug-industry middlemen backfires tucsonsentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tucsonsentinel.com Daily Mail and Mail on Sunday newspapers.